Deutsche Bank’s ESSA Pharma EPIX Stock Holding History

Deutsche Bank’s Portfolio EPIX Stock Details EPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-43,701	Closed	-$350K	–	4286
2021 Q3	$350K	Buy	43,701 +42,138	+2,696%	+$670K	﹤0.01%	3256
2021 Q2	$45K	Buy	+1,563	New	+$45.4K	﹤0.01%	4326
2020 Q1	–	Sell	-1,568	Closed	-$8K	–	4459
2019 Q4	$8K	Buy	+1,568	New	+$7.29K	﹤0.01%	4552

Other funds holding EPIX

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Deutsche Bank's EPIX Position: Q4 2021 in Review

Deutsche Bank sold out of ESSA Pharma (EPIX) in Q4 2021, closing a stake of 43,701 shares — an estimated $350K sold.

Deutsche Bank first reported a position in EPIX in Q4 2019 and held it in 3 quarters. The position peaked at $350K in Q3 2021. 60 funds tracked by Wall St. Rank hold EPIX as of Q4 2021.

Deutsche Bank reported no remaining ESSA Pharma position as of Q4 2021 after selling out during the quarter.
Deutsche Bank sold 43,701 ESSA Pharma shares in Q4 2021, an estimated $350K.
Deutsche Bank first reported a position in ESSA Pharma in Q4 2019 and held it in 3 quarters.
Deutsche Bank's ESSA Pharma position peaked at $350K in Q3 2021.
60 funds tracked by Wall St. Rank held ESSA Pharma as of Q4 2021.

Based on Deutsche Bank's 13F filing for Q4 2021, filed 11 Feb 2022.